PharmaSource’s Post

🔬 This week’s CDMO news: Lonza announces “One Lonza” strategy with focus on CDMO business. https://lnkd.in/e_a3AR52 EUROAPI announces leadership changes: new CEO and chair of the board appointed. Emmanuel Blin has been named Independent Chair of the Board of Directors, and David Seignolle assumes the role of Chief Executive Officer. https://lnkd.in/gfiQ-ryp Rocketvax AG collaborates with HALIX to develop next-gen COVID-19 vaccine. https://lnkd.in/gRDQix7d RTI Surgical transforms into Evergen (Formerly RTI Surgical), focuses on regenerative medicine. https://lnkd.in/gKj6ASD3 BioCentriq expands with 60,000 sq. ft. cell therapy facility in NJ. https://lnkd.in/gSs5KBBQ NorthStar Medical Radioisotopes, LLC and Ariceum Therapeutics Partner on Actinium-225 for Cutting-Edge Cancer Therapies. https://lnkd.in/gcV3FEy7 Viva Biotech establishes Boston branch. https://lnkd.in/gAcrGwu5 SK pharmteco unites global brands under one banner. https://lnkd.in/gnnbe8uX Evotec and Novo Nordisk’s LAB eN² selects first Projects for translational drug discovery. https://lnkd.in/g8B-m_ut Porton Pharma Solutions Ltd. partners with Aojin for XDC conjugate drug development. https://lnkd.in/gJHjJPjr Scinai Immunotherapeutics Ltd. establishes U.S. subsidiary for CDMO services. https://lnkd.in/gVM4y_cz Samsung Biologics achieves continued recognition in Dow Jones sustainability index for 2024. https://lnkd.in/gKYMrGxP Upperton Pharma Solutions appoints Lorna Patrick as chief operating officer. https://lnkd.in/gGsiRZwi For the latest CDMO News, sign up to our newsletter:  https://lnkd.in/gHxD3TEJ #CDMO #Pharma #ContractManufacturing